XPH vs. DIVP ETF Comparison
Comparison of SPDR S&P Pharmaceuticals ETF (XPH) to Cullen Enhanced Equity Income ETF (DIVP)
XPH
SPDR S&P Pharmaceuticals ETF
XPH Description
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a replication strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.
Grade (RS Rating)
Last Trade
$45.79
Average Daily Volume
62,203
44
DIVP
Cullen Enhanced Equity Income ETF
DIVP Description
DIVP invests in large- and mid-cap value stocks that generally have higher dividend yield than the average of the funds US benchmark. The fund identifies value stocks that have low price-to-earnings ratio with above-average earnings and dividend growth potential. Companies are screened using fundamental research. The fund may invest up to 30% in non-US companies in the form of ADRs. While the portfolio is not rebalanced systematically, weighting is roughly equal to avoid overweighting of individual securities. To generate additional income, the fund selectively writes covered call options with a target range of between 25-40%. However, the covered call overlay limits participation in potential gains if shares increase in value. The adviser may sell stocks that are no longer viewed as attractive based on growth potential, dividend yield, or price. As an actively managed ETF, the fund manager has full discretion to make buy, hold, or sell decisions at any time.Grade (RS Rating)
Last Trade
$27.14
Average Daily Volume
1,457
32
Performance
| Period | XPH | DIVP |
|---|---|---|
| 30 Days | 0.26% | 2.87% |
| 60 Days | 4.35% | 2.02% |
| 90 Days | 4.12% | 4.23% |
| 12 Months | 26.21% |
XPH Overweight 42 Positions Relative to DIVP
| Symbol | Grade | Weight | |
|---|---|---|---|
| CORT | B | 4.96% | |
| LBPH | A | 4.12% | |
| ITCI | B | 4.01% | |
| JAZZ | B | 3.94% | |
| VTRS | B | 3.73% | |
| AXSM | B | 3.59% | |
| EWTX | C | 3.42% | |
| CTLT | B | 3.41% | |
| ELAN | F | 3.35% | |
| PRGO | C | 3.35% | |
| RPRX | D | 3.18% | |
| JNJ | D | 3.17% | |
| ZTS | F | 3.15% | |
| PFE | D | 3.07% | |
| LLY | D | 2.94% | |
| TARS | B | 2.81% | |
| OGN | D | 2.58% | |
| SAVA | F | 2.57% | |
| ARVN | F | 2.53% | |
| PBH | B | 2.5% | |
| SUPN | B | 2.15% | |
| AMPH | F | 2.02% | |
| PCRX | D | 1.91% | |
| LGND | B | 1.77% | |
| ANIP | D | 1.54% | |
| COLL | D | 1.48% | |
| OCUL | D | 1.44% | |
| AMRX | D | 1.33% | |
| MNMD | C | 1.23% | |
| HRMY | D | 1.22% | |
| WVE | B | 1.17% | |
| HROW | D | 1.17% | |
| INVA | D | 0.98% | |
| EYPT | F | 0.94% | |
| LQDA | D | 0.89% | |
| PLRX | C | 0.87% | |
| FULC | D | 0.85% | |
| ELVN | D | 0.64% | |
| NUVB | C | 0.6% | |
| EOLS | D | 0.52% | |
| PHAT | F | 0.48% | |
| XERS | B | 0.46% |
XPH Underweight 30 Positions Relative to DIVP
| Symbol | Grade | Weight | |
|---|---|---|---|
| CSCO | A | -4.46% | |
| EOG | C | -4.39% | |
| MDT | D | -3.88% | |
| VICI | C | -3.83% | |
| DUK | C | -3.6% | |
| PPL | A | -3.6% | |
| CVX | A | -3.51% | |
| PM | A | -3.47% | |
| C | B | -3.35% | |
| TFC | B | -3.34% | |
| BAC | A | -3.33% | |
| KVUE | A | -3.28% | |
| CAG | D | -3.25% | |
| VZ | B | -3.24% | |
| CMCSA | C | -3.23% | |
| XOM | C | -3.22% | |
| SYY | C | -2.92% | |
| RTX | D | -2.89% | |
| DOC | C | -2.86% | |
| MO | A | -2.73% | |
| BAX | F | -2.67% | |
| IBM | C | -2.62% | |
| JCI | C | -2.55% | |
| JPM | B | -2.41% | |
| TRV | B | -2.21% | |
| DOW | F | -2.1% | |
| GD | F | -2.03% | |
| RIO | F | -1.81% | |
| GPC | D | -1.81% | |
| UPS | C | -1.75% |
XPH: Top Represented Industries & Keywords
DIVP: Top Represented Industries & Keywords
Compare ETFs
